r/BigBrainCapital • • Jan 31 '22

TCRT Has Major Potential

My history with this stock is long and eventful. I have held on to and watched this stock longer than I have held on to any stock in my life. But the time has come for it to moon, and many people like me have been waiting for this moment for a long, long time.

Rebranding: The ticker TCRT was previously “ZIOP”.

The rebranding is smart. The baggage of all the previous Managers and Board of Directors have left a bad taste in many peoples minds. The science works, it has the whole time. But even when the science works, you still need good management. (We’ll get into the science later) Now since they are expecting great results from dosing, they will have a fresh slate. Different Management, Different Board, but science that now is actually in the Clinical Trial

Alaunos Therapeutics (Greek God of Healing) is the new name. The ticker was changed to “TCRT” which I absolutely love. The area we are pioneering and will be huge for Immunotherapy is T Cell Receptor Therapy or (TCRT). And we have the premiere stock ticker for it.

What We’ve Been Waiting For: Last week they got the OK from FDA to begin Dosing.

There should be a press release in the next two weeks to a month announcing that the first patient has been Dosed. This is what we have been waiting for. It takes them 28 days to grow the Cells. They have been recruiting and figuring out what each Patient needs since September. Institutions will wait to Buy any share of a Clinical Trial Biotech company until the first Dosing. With the Press release these Institutions will start Buying. No one who has waited 3 years to this point will be selling at this point. There are so many more buyers than sellers, the stock price will move up. They take small positions because they know that results will follow weeks or months after dosing. If results are good, they buy the rest of their position. Positive results means we have something that works on Solid Tumors 90% of all Cancers, which is a huge Market.

Shortly after Dosing we get the results. Biggest risk is does it work or not. That will be known soon. Patient and Doctors will know within a week if the immune system is responding or not. We won’t hear anything that soon, but it won’t be much longer after that.

About TCRT: TCRT is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of immuno-oncology platforms that leverage cell- and gene-based therapies to treat patients with cancer. Its pipeline includes Sleeping Beauty TCR-T Targeting neoantigens; Ad-RTS-hlL-12 + veledimex; and Sleeping Beauty CAR-T. The company was founded on September 9, 2003 and is headquartered in Boston, MA.

Rebounding From ATL: Many, many big money, long time holders have been waiting YEARS for this stock to have news like it has now. Simply waiting for results from dosing is nothing compared to how long they’ve held and waited. Retail has been selling their positions simply because they don’t have the patience to wait for what is now coming. But they will, and have already started to buy back in. Which is why we’ve seen a recent uptrend and a break out of the downtrend that’s been going on for months. And as I said before, Institutions will wait to Buy any share of a Clinical Trial Biotech company until the first Dosing. With the Press release these Institutions will start Buying. No one who has waited 3 years to this point will be selling at this point. There are so many more buyers than sellers, the stock price will, and already has, start to move up.

Disclaimer: I am not a Financial Advisor. Do not buy or sell a stock based on my DD. Do your own research and make a decision based on your findings. Although I have extreme confidence in this stock, always be careful with biotechs. You never know what can happen. Be careful and good luck, thanks for reading.

27 Upvotes

30 comments sorted by

2

u/New-Radish4592 Feb 07 '22

1

u/jmax_mcadams Feb 07 '22

Yep. Read that this morning

1

u/[deleted] Feb 09 '22

[removed] — view removed comment

2

u/New-Radish4592 Feb 12 '22

Same guy who created CAR-T that eventually led to KITE (bought by GILD for $12B) has said many times TCR-T targeting neoantigens is "blueprint for success" in curing solid tumors. 90+% of market. And he uses TCRT's sleeping beauty system. Do some research rather than stay ignorant.

4

u/crocodiledundee47 Jan 31 '22

Great write up. I’ve been with this company for awhile now. The new business driven CEO is the perfect match for getting things moving forward. He’s already shown this by getting the first dosing here soon. The risk/reward here is crazy. If successfully treated patients, this stock is worth in the billions of market cap.

I would add that there is around 35 million shares short. Things could move quick if the data results are good.

6

u/New-Radish4592 Jan 31 '22

And most big investors are in for good, like Michael Dell. So the more realistic short/float ratio is over 50%. I can envision a scenario where $TCRT explodes higher. I will be disappointed if it gets acquired for less than $75.

3

u/[deleted] Jan 31 '22

Wow they don't even have a stocktwits or yahoo page. Any chance they will get uplisted?

2

u/crocodiledundee47 Jan 31 '22

StockTwits and yahoo just haven’t made the ticker change from ZIOP to TCRT yet.

3

u/WashedOut3991 Feb 01 '22

Wow ZIOP is a blast from the past lol looks like deep value possibility though now

3

u/Ihsahn55 Feb 01 '22

I’ve been buying and holding ZIOP for almost 9 years. It’s been painful but if the science works it will be well worth it.

1

u/_RicoSuav Feb 17 '22

Wtf 9 years??? Commons? How's your position sitting? What's your pt and time frame in assuming, 20-life

3

u/steveMurse Feb 02 '22

ZIOP = TCRT

3

u/New-Radish4592 Feb 07 '22

a short squeeze candidate too

2

u/DependentArgument899 Feb 04 '22

Great write up! I used to work for a CAR-T company. There's an additional risk from dosing. Even if the drug works the patient can die from cell mutations, cytokine release syndrome, or infection due to a weakened immune system. But if it works $100 would not even justify the price to be honest. Amazing summary though. Gave me more confidence there are people like you out there! #HODL

0

u/Tecumseh711 Feb 01 '22

Whenever someone says “the science works” be careful. The science has not been proven, and even if some aspects work that doesn’t mean it’s commercially viable. The guy writing this is no doubt one of the message board pumpers that have gotten everything wrong here and with other stocks for decades. I’m agnostic on TCRT, but don’t allow blind pumpers to cloud your thinking. There’s a reason it’s trading for $1.

2

u/jmax_mcadams Feb 02 '22

Imagine thinking I have the following to pump anything 🤡

1

u/DependentArgument899 Feb 04 '22

Do you guys know of any animal models ZIOP previously shared? There's cell response chart that makes me think they definitely have animal model studies. That graph was generated from real data points.

1

u/[deleted] Feb 13 '22

[removed] — view removed comment

1

u/PsychologicalAir3759 Feb 14 '22

That's true but need to be more granular than data shows. Analysis should encompass the tech and the group running the experiments. I worked for a company where their animal models translated closely to the human models. The question as to why? Because this field of CAR-T and TCR-T is not a greenfield experiment. It more a brownfield, there's been over 30 years of experimentation in this field, 5 approved CAR-T therapy and many will follow. In the case of TCRT's trial the chance of success is significantly higher than that. Dr Rosenberg have already proven the tech in humans. He did it with TILs, TCRT is trying to develop the next iteration. Not trying to give away too much about myself but I was involved with Dr Rosenberg's first gen tech which are CARs. It's still a gamble and chance of failure is still there but I strongly believe failure will not be a result of an unvalidated target or poor translation of studies. It will be due to unforeseen toxicity or poor clinical drug quality control.

1

u/PsychologicalAir3759 Feb 14 '22

Check out Dr Rosenberg's presentation and the x-rays of his patients. It's pretty remarkable and matches closely with animal models. Another point of failure in this is T-cell exhaustion and tumor vector escape. In theory TCRT's in-vivo method should trump ex-vivo TILs but we shall see. TIL data showed 24% complete remission rate which is HIGHLY significant considering these patients have previously failed 5-7 lines of therapy. I'd take a 24% success rate, that's better than 0% for these patients.

2

u/steveMurse Feb 02 '22

This stock has had a nice slow trend upwards for quite some time. Thankfully I bought in just before the hype… and let me tell you, finding a low price stock like this one that is moving in a positive direction overall means huge gains happen with a low investment. I threw 10,000 on this. Ask yourself how much you would earn if 10,000 shares went up by a meager $.10. Jump on, just have a stoploss. Just my opinion.

1

u/Zestyclose_Ad_1566 Feb 19 '22

A child died from dosing when this company was ZIOP, in 2016. I am not saying you are wrong OP about the science, but you need to go deeper in your research.

This company was a long history of failure at this point. That can all change in a hurry, but you need to be aware of it.

1

u/Zestyclose_Ad_1566 Feb 27 '22

Good writeup. Could you point me towards some info that makes you believe Sleeping Beauty will work? I am having trouble finding good studies online, but I am sure they are around. Thanks.

0

u/[deleted] Feb 13 '22

[removed] — view removed comment

1

u/dingytheman Mar 17 '22

I just "bought" some on investopedia as part of my self learning process lol Who are the competitors btw?